HCWB — HCW Biologics Inc.

HCWBHCW Biologics Inc.

NAS · US · Healthcare · Biotechnology · hcwbiologics.com

2.705USD-6.40%Mkt Cap: 17.44M USDP/E: —Last update: 2026-05-26

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products includ…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap17.44M USD

Enterprise Value22.72M USD

Revenue (TTM)6.59M USD

Gross Profit10.85K USD

Net Income (TTM)-7.96M USD

Revenue/Share2.076 USD

Last Price2.705 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees35

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-4.69

PEG—

EV/EBITDA-2.95

EV/Revenue3.45

P/S2.64

P/B3.06

EPS (TTM)-8.29

EPS (Forward)-0.55

52W Range

0.250029% of range8.746

52W High8.746 USD

52W Low0.2500 USD

Profitability

Gross Margin20.00%

Oper. Margin49.45%

EBITDA Margin-116.75%

Profit Margin-14677.14%

ROE-287.90%

ROA-32.46%

Growth

Revenue Growth129080.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF-13.39M USD

CapEx (TTM)—

FCF Margin-173.28%

FCF Yield-65.49%

Net Debt5.35M USD

Net Debt/EBITDA-0.69

Balance Sheet

Debt/Equity2.46

Current Ratio0.09

Quick Ratio0.07

Book Value/Sh0.8430 USD

Cash/Share0.1820 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:40

Split DateApr 11, 2025

Analyst Consensus

Rating—

Target (Mean)2.000 USD

Target Range2.000 USD – 2.000 USD

# Analysts1

Ownership

Shares Out.6.73M

Float6.15M

Insiders8.60%

Institutions12.23%

Short Interest

Short Ratio0.3d

Short % Float9.28%

Short % Out.8.48%

Shares Short570.86K

Short (prev mo.)110.64K

Technical

SMA 500.5635 (+380.0%)

SMA 2002.124 (+27.3%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)25.29M

Avg Vol (10d)69.42M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—